NITRIC-OXIDE CONTRIBUTES TO FUNCTIONAL HYPEREMIA IN CEREBELLAR CORTEX

被引:58
|
作者
IADECOLA, C [1 ]
LI, J [1 ]
EBNER, TJ [1 ]
XU, XH [1 ]
机构
[1] UNIV MINNESOTA, SCH MED, DEPT NEUROSURG, MINNEAPOLIS, MN 55455 USA
关键词
N-OMEGA-NITRO-L-ARGININE; CEREBRAL CIRCULATION; NITRIC OXIDE SYNTHASE; PARALLEL FIBERS; LASER DOPPLER; FIELD POTENTIALS;
D O I
10.1152/ajpregu.1995.268.5.R1153
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
We used the parallel fibers (PF) system of the cerebellar cortex as a model to investigate the role of nitric oxide (NO) in the increases in blood flow elicited by neural activation. Rats were anesthetized with halothane and ventilated. The vermis was exposed, and the site was superfused with Ringer (37 degrees C; pH 7.3-7.4). PF were stimulated electrically (100 mu A; 30 Hz), and the associated changes in cerebellar cortex blood flow (BFcrb) were monitored by laser-Doppler flowmetry. The field potentials evoked by PF stimulation were recorded using microelectrodes. During Ringer superfusion (n = 7), PF stimulation increased BFcrb (+52 +/- 4%). Topical application of the NO synthase (NOS) inhibitor N-omega-nitro-L-arginine (L-NNA; 0.1-1 mM) attenuated the increases in BFcrb dose dependently and by 50 +/- 4% at 1 mM (n = 9;P < 0.001; analysis of variance and Tukey's test). L-NNA (1 mM) inhibited NOS catalytic activity, assessed ex vivo using the citrulline assay, by 95 +/- 9% (P < 0.001). L-NNA did not influence the field potentials evoked by PF stimulation. D-NNA (1 mM; n = 6), the inactive stereoisomer of nitroarginine, did not attenuate the BFcrb response (P > 0.05). Methylene blue (1 mM; n = 7) reduced the response by 41 +/- 9% (P < 0.01) without affecting NOS catalytic activity (P < 0.05). The increases in BFcrb were not affected by lesioning the NOS-containing nerve fibers innervating cerebral vessels, indicating that these nerves are not the source of NO. Thus the increases in BFcrb elicited by activation of PF are, in part, mediated by NO produced in the molecular layer during neural activity. The results indicated that NO participates in the coupling of function activity to blood flow and support the hypothesis that NO is one of the mediators responsible for functional hyperemia in the central nervous system.
引用
收藏
页码:R1153 / R1162
页数:10
相关论文
共 50 条
  • [1] NITRIC-OXIDE AND ADENOSINE MEDIATE FUNCTIONAL HYPEREMIA IN CEREBELLAR CORTEX
    LI, J
    IADECOLA, C
    FASEB JOURNAL, 1995, 9 (03): : A594 - A594
  • [2] NITRIC-OXIDE AND ADENOSINE MEDIATE FUNCTIONAL HYPEREMIA IN CEREBELLAR CORTEX
    LI, J
    IADECOLA, C
    STROKE, 1995, 26 (01) : 179 - 179
  • [3] NITRIC-OXIDE AND ADENOSINE MEDIATE VASODILATION DURING FUNCTIONAL ACTIVATION IN CEREBELLAR CORTEX
    LI, J
    IADECOLA, C
    NEUROPHARMACOLOGY, 1994, 33 (11) : 1453 - 1461
  • [4] ROLE OF NITRIC-OXIDE (NO) IN HYPEREMIA IN THE ANESTHETIZED DOG
    MCAULIFFE, SAG
    MOORS, JA
    POUCHER, SM
    SNOW, HM
    JOURNAL OF PHYSIOLOGY-LONDON, 1994, 480P : P137 - P138
  • [5] NITRIC-OXIDE (NO) AND POSTPRANDIAL JEJUNAL HYPEREMIA AND MOTILITY
    ALEMAYEHU, A
    LI, S
    CHOU, CC
    FASEB JOURNAL, 1994, 8 (05): : A870 - A870
  • [6] ROLE OF ENDOTHELIUM-DERIVED NITRIC-OXIDE AND ADENOSINE IN FUNCTIONAL MYOCARDIAL HYPEREMIA
    MAEKAWA, K
    SAITO, D
    OBAYASHI, N
    UCHIDA, S
    HARAOKA, S
    AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 267 (01): : H166 - H173
  • [7] ENDOTHELIUM-DERIVED NITRIC-OXIDE CONTRIBUTES TO EXERCISE-INDUCED HYPEREMIA IN THE HUMAN FOREARM
    MEREDITH, IT
    JAIN, RK
    ANDERSON, TJ
    GANZ, P
    CREAGER, MA
    CIRCULATION, 1994, 90 (04) : 295 - 295
  • [8] THE ROLE OF NITRIC-OXIDE IN PORTAL HYPERTENSIVE SPLANCHNIC HYPEREMIA
    WU, Y
    BURNS, RC
    SITZMANN, JV
    HEPATOLOGY, 1992, 16 (04) : A116 - A116
  • [9] NITRIC-OXIDE SYNTHASE INHIBITORS DO NOT ALTER FUNCTIONAL HYPEREMIA IN CANINE SKELETAL-MUSCLE
    BARCLAY, JK
    WOODLEY, NE
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1994, 72 (09) : 1035 - 1041
  • [10] Nitric oxide contributes to adenosine-induced hyperemia in retina
    Gidday, JM
    Meier, JA
    Zhu, Y
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (03) : 2104 - 2104